July 25, 2019
From New England to the Mid-Atlantic, a rising tide lifts all boats across the biopharma value chain.
May 23, 2019
Expert Opinion Article contributed by Jim Neal, CEO of the biotech enterprise XOMA.
April 24, 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.
April 01, 2019
The U.S. biopharmaceuticals industry continues to grapple with the perennial issue of drug pricing.
February 27, 2019
Opportunities grow for contract service providers.
February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.
October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.
August 30, 2018
Precision medicine and the understanding that every patient is different are driving drug discovery.
June 06, 2018
By better defining addressable patient populations and more precisely predicting likely individual responses, companies are able to reduce a great deal of risk in their clinical trials.
April 26, 2018
The infectious disease space is one of high unmet need. However, this particular market segment carries an additional challenge: drug resistance.